Atlas Trials

Study of Interleukin-2, Interferon-alpha and Bevacizumab in Metastatic Kidney Cancer

Clinical trial NCT01274273 · UNKNOWN

Trial details

NCT number
NCT01274273
Sponsor
University of Aarhus
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Renal Cell Carcinoma
Start date
2009-10-01
Primary completion
2015-12-01
Enrollment
118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.